1. Home
  2. INDP vs AUUD Comparison

INDP vs AUUD Comparison

Compare INDP & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • AUUD
  • Stock Information
  • Founded
  • INDP 2000
  • AUUD 2012
  • Country
  • INDP United States
  • AUUD United States
  • Employees
  • INDP N/A
  • AUUD N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • AUUD Computer Software: Prepackaged Software
  • Sector
  • INDP Health Care
  • AUUD Technology
  • Exchange
  • INDP Nasdaq
  • AUUD Nasdaq
  • Market Cap
  • INDP 4.0M
  • AUUD 4.1M
  • IPO Year
  • INDP N/A
  • AUUD 2021
  • Fundamental
  • Price
  • INDP $2.60
  • AUUD $1.20
  • Analyst Decision
  • INDP Strong Buy
  • AUUD
  • Analyst Count
  • INDP 1
  • AUUD 0
  • Target Price
  • INDP $140.00
  • AUUD N/A
  • AVG Volume (30 Days)
  • INDP 67.5K
  • AUUD 2.0M
  • Earning Date
  • INDP 11-07-2025
  • AUUD 11-06-2025
  • Dividend Yield
  • INDP N/A
  • AUUD N/A
  • EPS Growth
  • INDP N/A
  • AUUD N/A
  • EPS
  • INDP N/A
  • AUUD N/A
  • Revenue
  • INDP N/A
  • AUUD N/A
  • Revenue This Year
  • INDP N/A
  • AUUD N/A
  • Revenue Next Year
  • INDP N/A
  • AUUD N/A
  • P/E Ratio
  • INDP N/A
  • AUUD N/A
  • Revenue Growth
  • INDP N/A
  • AUUD N/A
  • 52 Week Low
  • INDP $2.22
  • AUUD $1.09
  • 52 Week High
  • INDP $47.60
  • AUUD $14.60
  • Technical
  • Relative Strength Index (RSI)
  • INDP 40.51
  • AUUD 31.58
  • Support Level
  • INDP $2.45
  • AUUD $1.09
  • Resistance Level
  • INDP $3.76
  • AUUD $1.28
  • Average True Range (ATR)
  • INDP 0.28
  • AUUD 0.09
  • MACD
  • INDP -0.06
  • AUUD 0.01
  • Stochastic Oscillator
  • INDP 26.80
  • AUUD 21.32

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About AUUD Auddia Inc.

Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.

Share on Social Networks: